The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence
Open accessAbstract
There has been an increasing demand for the development of nanocarriers targeting multiple diseases with a broad range of properties. Due to their tiny size, giant surface area and feasible targetability, nanocarriers have optimized efficacy, decreased side effects and improved stability over conventional drug dosage forms. There are diverse types of nanocarriers that have been synthesized for drug delivery, including dendrimers, liposomes, solid lipid nanoparticles, polymersomes, polymer–drug conjugates, polymeric nanoparticles, peptide nanoparticles, micelles, nanoemulsions, nanospheres, nanocapsules, nanoshells, carbon nanotubes and gold nanoparticles, etc. Several characterization techniques have been proposed and used over the past few decades to control and predict the behavior of nanocarriers both in vitro and in vivo. In this review, we describe some fundamental in vitro, ex vivo, in situ and in vivo characterization methods for most nanocarriers, emphasizing their advantages and limitations, as well as the safety, regulatory and manufacturing aspects that hinder the transfer of nanocarriers from the laboratory to the clinic. Moreover, integration of artificial intelligence with nanotechnology, as well as the advantages and problems of artificial intelligence in the development and optimization of nanocarriers, are also discussed, along with future perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Transmission Electron Microscopy
Williams, D. B., & Carter, C. B. (1996) · Springer eBooks · doi:10.1007/978-1-4757-2519-3 · Cited by 1,817
Clogston, J. D., & Patri, A. K. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60327-198-1_6 · Cited by 1,324
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.20 · Cited by 1,309
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Murdock, R. C., Braydich-Stolle, L., Schrand, A. M., Schlager, J. J., & Hussain, S. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm240 · Cited by 1,093
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Detection and localization of single molecular recognition events using atomic force microscopy
Hinterdorfer, P., & Dufrêne, Y. F. (2006) · Nature Methods · doi:10.1038/nmeth871 · Cited by 1,055
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Pelaz, B., del Pino, P., Maffre, P., Hartmann, R., Gallego, M., Rivera-Fernández, S., de la Fuente, J. M., Nienhaus, G. U., & Parak, W. J. (2015) · ACS Nano · doi:10.1021/acsnano.5b01326 · Cited by 890
McConnell, E. L., Basit, A. W., & Murdan, S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0008 · Cited by 654
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 617
Caco-2 cell permeability assays to measure drug absorption
van Breemen, R. B., & Li, Y. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.175 · Cited by 602
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death
Khanna, P., Ong, C., Bay, B., & Baeg, G. (2015) · Nanomaterials · doi:10.3390/nano5031163 · Cited by 580
Surface Modifications of Nanoparticles for Stability in Biological Fluids
Guerrini, L., Alvarez-Puebla, R. A., & Pazos-Perez, N. (2018) · Materials · doi:10.3390/ma11071154 · Cited by 571
Kim, S., Shi, Y., Kim, J. Y., Park, K., & Cheng, J.-X. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903380446 · Cited by 549
Fischer-Cripps, A. C. (2011) · Mechanical Engineering Series · doi:10.1007/978-1-4419-9872-9 · Cited by 541
Strategies to improve micelle stability for drug delivery
Lu, Y., Zhang, E., Yang, J., & Cao, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2152-3 · Cited by 530
Biopolymer-based nanoparticles and microparticles: Fabrication, characterization, and application
Joye, I. J., & McClements, D. J. (2014) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2014.07.002 · Cited by 527
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Majumder, J., Taratula, O., & Minko, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.010 · Cited by 394
Powers, K. W., Palazuelos, M., Moudgil, B. M., & Roberts, S. M. (2007) · Nanotoxicology · doi:10.1080/17435390701314902 · Cited by 383
Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies
Cho, E. J., Holback, H., Liu, K. C., Abouelmagd, S. A., Park, J., & Yeo, Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300697h · Cited by 382
Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1416 · Cited by 380
Molecular design of biodegradable polymeric micelles for temperature-responsive drug release
Nakayama, M., Okano, T., Miyazaki, T., Kohori, F., Sakai, K., & Yokoyama, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.007 · Cited by 376
In vivo toxicity of cationic micelles and liposomes
Knudsen, K. B., Northeved, H., Kumar EK, P., Permin, A., Gjetting, T., Andresen, T. L., Larsen, S., Wegener, K. M., Lykkesfeldt, J., Jantzen, K., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.08.004 · Cited by 356
Toxicity of Nanomaterials: Exposure, Pathways, Assessment, and Recent Advances
Ganguly, P., Breen, A., & Pillai, S. C. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00068 · Cited by 341
BUNJES, H., & UNRUH, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.013 · Cited by 336
Nanoparticle: An overview of preparation and characterization
Pal, S. L., Jana, U., Manna, P. K., Mohanta, G. P., & Manavalan, R. (2011) · Cited by 333
Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes
Gaucher, G., Marchessault, R. H., & Leroux, J.-C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.012 · Cited by 315
Protein nanoparticle: A unique system as drug delivery vehicles
Jahanshahi, M., & Babaei, Z. (2008) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v7i25.59701 · Cited by 314
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Lu, Y., Yue, Z., Xie, J., Wang, W., Zhu, H., Zhang, E., & Cao, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0234-x · Cited by 313
Modi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 307
Light scattering: A review of particle characterization applications
Xu, R. (2015) · Particuology · doi:10.1016/j.partic.2014.05.002 · Cited by 305
Zhao, Y., Wang, Y., Ran, F., Cui, Y., Liu, C., Zhao, Q., Gao, Y., Wang, D., & Wang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-03834-2 · Cited by 301
Stability of Self-Assembled Polymeric Micelles in Serum
Lu, J., Owen, S. C., & Shoichet, M. S. (2011) · Macromolecules · doi:10.1021/ma200675w · Cited by 299
Cooley, M., Sarode, A., Hoore, M., Fedosov, D. A., Mitragotri, S., & Sen Gupta, A. (2018) · Nanoscale · doi:10.1039/c8nr04042g · Cited by 279
Cell culture-based models for intestinal permeability: A critique
Balimane, P. V., & Chong, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03354-9 · Cited by 278
Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines
Volpe, D. A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.149 · Cited by 252
High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis
Gobezie, R., Kho, A., Krastins, B., Sarracino, D. A., Thornhill, T. S., Chase, M., Millett, P. J., & Lee, D. M. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2172 · Cited by 249
Paiva-Santos, A. C., Herdade, A. M., Guerra, C., Peixoto, D., Pereira-Silva, M., Zeinali, M., Mascarenhas-Melo, F., Paranhos, A., & Veiga, F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120311 · Cited by 225
Everted gut sac model as a tool in pharmaceutical research: limitations and applications
Alam, M. A., Al-Jenoobi, F. I., & Al-mohizea, A. M. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01391.x · Cited by 221
Computational pharmaceutics - A new paradigm of drug delivery
Wang, W., Ye, Z., Gao, H., & Ouyang, D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.030 · Cited by 218
Drug release from nanomedicines: selection of appropriate encapsulation and release methodology
Wallace, S. J., Li, J., Nation, R. L., & Boyd, B. J. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0064-4 · Cited by 217
Chitosan/β-lactoglobulin core–shell nanoparticles as nutraceutical carriers
Chen, L., & Subirade, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.011 · Cited by 217
Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study
Chaubal, M. V., & Popescu, C. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9625-0 · Cited by 216
Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients
Chariou, P. L., Ortega-Rivera, O. A., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c00173 · Cited by 212
Animal versus human oral drug bioavailability: Do they correlate?
Musther, H., Olivares-Morales, A., Hatley, O. J. D., Liu, B., & Rostami Hodjegan, A. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.018 · Cited by 211
Surface Analysis of Nanocomplexes by X-ray Photoelectron Spectroscopy (XPS)
Korin, E., Froumin, N., & Cohen, S. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00040 · Cited by 207
Wet STEM: A new development in environmental SEM for imaging nano-objects included in a liquid phase
Bogner, A., Thollet, G., Basset, D., Jouneau, P.-H., & Gauthier, C. (2005) · Ultramicroscopy · doi:10.1016/j.ultramic.2005.05.005 · Cited by 206
Uprit, S., Kumar Sahu, R., Roy, A., & Pare, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.11.005 · Cited by 201
Shen, J., & Burgess, D. J. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0129-z · Cited by 201
Biopharmaceutics classification and intestinal absorption study of apigenin
Zhang, J., Liu, D., Huang, Y., Gao, Y., & Qian, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.002 · Cited by 201
Saupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 199
Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems
Sitterberg, J., Özcetin, A., Ehrhardt, C., & Bakowsky, U. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.005 · Cited by 187
Chen, T., He, B., Tao, J., He, Y., Deng, H., Wang, X., & Zheng, Y. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.009 · Cited by 186
Predicting physical stability of solid dispersions by machine learning techniques
Han, R., Xiong, H., Ye, Z., Yang, Y., Huang, T., Jing, Q., Lu, J., Pan, H., Ren, F., & Ouyang, D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.030 · Cited by 180
Buckley, S. T., Fischer, S. M., Fricker, G., & Brandl, M. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.12.007 · Cited by 179
Pitfalls and novel applications of particle sizing by dynamic light scattering
Fischer, K., & Schmidt, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.003 · Cited by 166
Hühmer, A. F., Biringer, R. G., Amato, H., Fonteh, A. N., & Harrington, M. G. (2006) · Disease Markers · doi:10.1155/2006/158797 · Cited by 165
Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model
Ruan, L.-P., Chen, S., Yu, B., Zhu, D.-N., CORDELL, G. A., & Qiu, S. X. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.01.013 · Cited by 164
A novel USP apparatus 4 based release testing method for dispersed systems
Bhardwaj, U., & Burgess, D. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.009 · Cited by 160
Huynh, L., Neale, C., Pomès, R., & Allen, C. J. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.05.006 · Cited by 159
Na, K., & Bae, Y. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1015370532543 · Cited by 158
Techniques for the experimental investigation of the protein corona
Carrillo-Carrion, C., Carril, M., & Parak, W. J. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.02.009 · Cited by 158
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 148
Modeling Drug-Carrier Interaction in the Drug Release from Nanocarriers
Zeng, L., An, L., & Wu, X. (2011) · Journal of Drug Delivery · doi:10.1155/2011/370308 · Cited by 144
Dissolution Studies of Poorly Soluble Drug Nanosuspensions in Non-sink Conditions
Liu, P., Wulf, O. D., Laru, J., Heikkilä, T., van Veen, B., Kiesvaara, J., Hirvonen, J. J., Peltonen, L., & Laaksonen, T. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9960-2 · Cited by 143
Saifi, Z., Rizwanullah, M., Mir, S. R., & Amin, S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101634 · Cited by 140
Picton, L., Bataille, I., & Müller, G. (2000) · Carbohydrate Polymers · doi:10.1016/s0144-8617(99)00139-3 · Cited by 138
Is dialysis a reliable method for studying drug release from nanoparticulate systems?—A case study
Zambito, Y., Pedreschi, E., & Di Colo, G. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.020 · Cited by 136
Shono, Y., Jantratid, E., Kesisoglou, F., Reppas, C. I., & Dressman, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.009 · Cited by 136
Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy
Ding, Y., Xu, Y., Yang, W., Niu, P., Li, X., Chen, Y., Li, Z., Liu, Y., An, Y., Liu, Y., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100970 · Cited by 131
Egorov, E., Pieters, C., Korach-Rechtman, H., Shklover, J., & Schroeder, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00929-2 · Cited by 131
Watanabe, M., Kawano, K., Yokoyama, M., Opanasopit, P., Okano, T., & Maitani, Y. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.030 · Cited by 128
Badr-Eldin, S. M., Aldawsari, H. M., Labib, G. S., & El-Kamel, A. H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74771 · Cited by 126
Self-citationApplication of Method Suitability for Drug Permeability Classification
Volpe, D. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9227-8 · Cited by 124
Agrahari, V., Burnouf, P., Burnouf, T., & Agrahari, V. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.008 · Cited by 124
Hanafy, A. S., Farid, R. M., & El-Gamal, S. S. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1062897 · Cited by 123
Self-citationWhat is a Suitable Dissolution Method for Drug Nanoparticles?
Heng, D., Cutler, D. J., Chan, H., Yun, J., & Raper, J. A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9560-0 · Cited by 122
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery
Hu, X., Fan, W., Yu, Z., Lü, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., & Wu, W. (2015) · Nanoscale · doi:10.1039/c5nr07474f · Cited by 120
Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20591 · Cited by 119
Rapalli, V. K., Kaul, V., Gorantla, S., Waghule, T., Dubey, S. K., Pandey, M. M., & Singhvi, G. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.117392 · Cited by 119
Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
Zeb, A., Rana, I., Choi, H.-I., Lee, C., Baek, S.-W., Lim, C.-W., Khan, N., Arif, S. T., Sahar, N.-U., Alvi, A. M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121184 · Cited by 116
Can machine learning predict drug nanocrystals?
He, Y., Ye, Z., Liu, X., Wei, Z., Qiu, F., Li, H., Zheng, Y., & Ouyang, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.043 · Cited by 115
The Long View of Nanotechnology Development: The National Nanotechnology Initiative at 10 Years
Roco, M. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-1168-6_1 · Cited by 113
Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes
Reboredo, C., González-Navarro, C. J., Martínez-Ohárriz, M. C., Martínez‐López, A. L., & Irache, J. M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120287 · Cited by 112
Juenemann, D., Jantratid, E., Wagner, C., Reppas, C. I., Vertzoni, M., & Dressman, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.10.012 · Cited by 108
Gupta, R., Shea, J., Scaife, C. L., Шурлыгина, А. В., & Rapoport, N. Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.019 · Cited by 107
A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes
Xu, X., Khan, M. A., & Burgess, D. J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.030 · Cited by 106
Pratiwi, D., Fawcett, J. P., Gordon, K. C., et al. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00113-3 · Cited by 102
Bednarski, M., Dudek, M., Knutelska, J., Nowiński, L., Sapa, J., Zygmunt, M., Nowak, G., Luty–Błocho, M., Wojnicki, M., Fitzner, K., et al. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.10.019 · Cited by 102
Development of paclitaxel-TyroSpheres for topical skin treatment
Kilfoyle, B. E., Sheihet, L., Zhang, Z., Laohoo, M., Kohn, J., & Michniak‐Kohn, B. B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.021 · Cited by 101
Tolentino, S., Pereira, M. N., Cunha‐Filho, M., Gratieri, T., & Gelfuso, G. M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117295 · Cited by 96
Recent progress in polymeric non-invasive insulin delivery
Sabbagh, F., Muhamad, I. I., Niazmand, R., Dikshit, P. K., & Kim, B. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.134 · Cited by 96
Accelerated Caco-2 cell permeability model for drug discovery
Sevin, E., Dehouck, L., Costa, A. D., Cecchelli, R., Dehouck, M., Lundquist, S., & Culot, M. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.07.004 · Cited by 95
Moreno‐Bautista, G., & Tam, K. C. (2011) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.07.032 · Cited by 94
The Study on the Entrapment Efficiency and In Vitro Release of Puerarin Submicron Emulsion
Yue, P., Lu, X.-Y., Zhang, Z.-Z., Yuan, H.-L., Zhu, W., Zheng, Q., & Yang, M. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9216-3 · Cited by 93
Proteomic Analyses of the Vitreous Humour
Angi, M., Kalirai, H., Coupland, S. E., Damato, B. E., Semeraro, F., & Romano, M. R. (2012) · Mediators of Inflammation · doi:10.1155/2012/148039 · Cited by 90
Saccharide Effect on the Lower Critical Solution Temperature of Thermosensitive Polymers
Kim, Y. H., Kwon, I. C., Bae, Y. H., & Kim, S. W. (1995) · Macromolecules · doi:10.1021/ma00108a022 · Cited by 89
Duarte, Y., Márquez‐Miranda, V., Miossec, M. J., & González-Nilo, F. D. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1554 · Cited by 89
Real-time electrochemical monitoring of drug release from therapeutic nanoparticles
Mora, L. V., Chumbimuni‐Torres, K. Y., Clawson, C., Hernández, L., Zhang, L., & Wang, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.002 · Cited by 87
Multifunctional Nanocarriers for Lung Drug Delivery
Pontes, J. F., & Grenha, A. (2020) · Nanomaterials · doi:10.3390/nano10020183 · Cited by 87
Pascucci, L., & Scattini, G. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129648 · Cited by 87
Shah, P., Chavda, K., Vyas, B., & Patel, S. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00839-9 · Cited by 87
In situ perfusion in rodents to explore intestinal drug absorption: Challenges and opportunities
Stappaerts, J., Brouwers, J., Annaert, P., & Augustijns, P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.035 · Cited by 86
Magnetic and pH-responsive magnetic nanocarriers
Nawaz, M., Slimani, Y., Ercan, İ., Lima-Tenório, M. K., Neto, E. T. T., Kaewsaneha, C., & Elaïssari, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-101995-5.00002-7 · Cited by 84
Stability of Liposomes on Long Term Storage
Hernández‐Caselles, T., Villalaı́n, J., & Gómez-Fernández, J. C. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06578.x · Cited by 83
In vitro toxicity assessment of oral nanocarriers
Ciappellano, S. G., Tedesco, E., Venturini, M., & Benetti, F. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.007 · Cited by 83
Alam, M. I., Baboota, S., Ahuja, A., Ali, M., Ali, J., Sahni, J. K., & Bhatnagar, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.004 · Cited by 82
Drug uptake transporters in antiretroviral therapy
Minuesa, G., Huber‐Ruano, I., Pastor‐Anglada, M., Koepsell, H., Clotet, B., & Martínez‐Picado, J. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.007 · Cited by 79
Zhai, J., Tan, F. H., Luwor, R. B., Reddy, T. S., Ahmed, N., Drummond, C. J., & Tran, N. L. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00269 · Cited by 79
Murthy, A. N., Ravi, P. R., Kathuria, H., & Vats, R. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119731 · Cited by 79
An integrated early formulation strategy – From hit evaluation to preclinical candidate profiling
Maas, J., Kamm, W., & Hauck, G. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.011 · Cited by 78
How to measure release from nanosized carriers?
Nothnagel, L., & Wacker, M. G. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.05.004 · Cited by 78
In vitro drug release mechanism from lipid nanocapsules (LNC)
Abdel-Mottaleb, M. M. A., Neumann, D., & Lamprecht, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.001 · Cited by 77
Sievens-Figueroa, L., Pandya, N., Bhakay, A., Keyvan, G., Michniak‐Kohn, B. B., Bilgili, E. A., & Davé, R. N. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9875-3 · Cited by 77
Overview of Nanoemulsion Properties: Stability, Rheology, and Appearance
Zhang, Z., & McClements, D. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811838-2.00002-3 · Cited by 75
Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals
Crisp, M. T., Tucker, C. J., Rogers, T. L., Williams, R. O., & Johnston, K. P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.011 · Cited by 73
Huguet-Casquero, A., Xu, Y., Gaínza, E., Pedraz, J. L., & Beloqui, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119515 · Cited by 70
Comparative investigations on in vitro serum stability of polymeric micelle formulations
Miller, T., Rachel, R., Besheer, A., Uezguen, S., Weigandt, M., & Goepferich, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-011-0555-x · Cited by 69
El-Ghareb, W. I., Swidan, M. M., Ibrahim, I. T., El-Bary, A. A., Tadros, M. I., & Sakr, T. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119514 · Cited by 67
El-Salamouni, N. S., Gowayed, M. A., Seiffein, N. L., Abd-el-Moneim, R., Kamel, M. A. E.-N., & Labib, G. S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120091 · Cited by 66
Self-citationIn-Vitro and In-Vivo Study of Indomethacin Loaded Gelatin Nanoparticles
Kumar, R., Nagarwal, R. C., Dhanawat, M., & Pandit, J. K. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1290 · Cited by 65
Sheshala, R., Anuar, N. K., Samah, N. H. A., & Wong, T. W. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1362-7 · Cited by 63
Vajedi, F. S., Dehghani, H., & Zarrabi, A. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111627 · Cited by 62
Xie, L., Beyer, S., Vogel, V., Wacker, M. G., & Mäntele, W. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.080 · Cited by 60
Bridging communities in the field of nanomedicine
Halamoda‐Kenzaoui, B., Baconnier, S., Bastogne, T., Bazile, D., Boisseau, P., Borchard, G., Borgos, S. E., Calzolai, L., Cederbrant, K., Felice, G. D., et al. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.04.011 · Cited by 57
Basalious, E. B., & Shamma, R. N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.075 · Cited by 56
Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles
Michalowski, C. B., Guterres, S. S., & Costa, T. D. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2004.04.002 · Cited by 56
Aboali, F. A., Habib, D. A., Elbedaiwy, H. M., & Farid, R. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119835 · Cited by 55
Self-citationComparative drug release studies of two cationic drugs from pH-responsive nanogels
Tan, J. P. K., Goh, C. H., & Tam, K. C. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.08.010 · Cited by 54
Roursgaard, M., Knudsen, K. B., Northeved, H., Persson, M., Christensen, T., Kumar, P. E. K., Permin, A., Andresen, T. L., Gjetting, T., Lykkesfeldt, J., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.08.002 · Cited by 54
Kim, J.-E., Yoon, I., Cho, H., Kim, D., Choi, Y.-H., & Kim, D.-D. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.01.016 · Cited by 52
In vitro release testing methods for vitamin E nanoemulsions
Morais, J. M., & Burgess, D. J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.063 · Cited by 52
Radwan, S. E.-S., Sokar, M. S., Abdelmonsif, D. A., & El-Kamel, A. H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.072 · Cited by 52
Janas, C., Mast, M.-P., Kirsamer, L., Angioni, C., Gao, F. G., Mäntele, W., Dressman, J., & Wacker, M. G. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.006 · Cited by 51
Preparation and Characterization of Magnetic Chitosan Microcapsules
Xiong, X., Wang, Y., Zou, W., Duan, J., & Chen, Y. (2012) · Journal of Chemistry · doi:10.1155/2013/585613 · Cited by 48
Ma, B., He, L., You, Y., Mo, J., & Chen, T. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1425779 · Cited by 46
Singh, G., & Pai, R. S. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12232 · Cited by 45
Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein
Yao, W., Xu, Z., Sun, J., Luo, J., Wei, Y., & Zou, J. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105713 · Cited by 45
Hoesli, C. A., Kiang, R. L. J., Mocinecová, D., Speck, M., Mošková, D. J., Donald‐Hague, C., Lacı́k, I., Kieffer, T. J., & Piret, J. M. (2012) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32667 · Cited by 44
Xu, X., Deng, Deng, Fu, Tong, T., Liu, Wei, W., Xu, Zeng, & Yu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28348 · Cited by 43
Mills, K. C., Ostraat, M. L., Guzan, K. A., & Murry, D. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40722 · Cited by 42
El-Salamouni, N. S., Farid, R. M., El-Kamel, A. H., & El-Gamal, S. S. (2018) · Journal of Microencapsulation · doi:10.1080/02652048.2018.1425753 · Cited by 42
Self-citationTrousil, J., Pavliš, O., Kubíčková, P., Škorič, M., Marešová, V., Pavlová, E., Knudsen, K. D., Dai, Y.-S., Zimmerman, M. D., Dartois, V. A., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.026 · Cited by 42
Fresta, M., Mancuso, A., Cristiano, M. C., Urbanek, K., Cilurzo, F., Cosco, D., Iannone, M., & Paolino, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111127 · Cited by 42
Javed, I., Hussain, S. Z., Shahzad, A., Khan, J. M., Ur-Rehman, H., Rehman, M., Usman, F., Razi, M. T., Shah, M. R., & Hussaın, I. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.022 · Cited by 41
Computational amphiphilic materials for drug delivery
Thota, N., & Jiang, J. (2015) · Frontiers in Materials · doi:10.3389/fmats.2015.00064 · Cited by 38
Impact of drug particle shape on permeability and cellular uptake in the lung
Zellnitz, S., Zellnitz, L., Müller, M., Meindl, C., Schröttner, H., & Fröhlich, E. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105065 · Cited by 36
Xie, X., Li, Y., Zhao, D., Fang, C., He, D., Yang, Q., Yang, L., Chen, R., Tan, Q., & Zhang, J. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102261 · Cited by 36
Bubble-generating nano-lipid carriers for ultrasound/CT imaging-guided efficient tumor therapy
Zhang, N., Li, J., Hou, R., Zhang, J., Wang, P., Liu, X., & Zhang, Z. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.081 · Cited by 35
Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.042 · Cited by 35
Vachhani, S., & Kleinstreuer, C. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104103 · Cited by 35
Farid, R. M., Gaafar, P. M. E., Hazzah, H. A., Helmy, M. W., & Abdallah, O. Y. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0428 · Cited by 34
Self-citationSolution calorimetry as an alternative approach for dissolution testing of nanosuspensions
Kayaert, P., Li, B., Jimidar, I., Rombaut, P., Ahssini, F., & den Mooter, G. V. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.009 · Cited by 33
Zhang, Y., Wang, H., Li, C., Sun, B., Yu, W., Wang, S., & Gao, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1227-9 · Cited by 32
Wang, M., Yuan, Y., Gao, Y., Ma, H., Xu, H., Zhang, X., & Pan, W. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.641565 · Cited by 32
Shah, B. M., Khunt, D., & Misra, M. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00156-5 · Cited by 31
Yan, G., Zong, R.-F., Li, L., Fu, T., Liu, F., & Yu, X. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0275-7 · Cited by 30
Kestens, V., Coleman, V. A., Temmerman, P.-J. D., Minelli, C., Woehlecke, H., & Roebben, G. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b01714 · Cited by 29
Davis, J. L., Zhang, Y., Yi, S., Du, F., Song, K.-H., Scott, E. A., Sun, C., & Zhang, H. F. (2020) · Langmuir · doi:10.1021/acs.langmuir.9b03149 · Cited by 27
Ramirez, L. M. F., Rihouey, C., Chaubet, F., Cerf, D. L., & Picton, L. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462404 · Cited by 26
Inchaurraga, L., Martínez‐López, A. L., Abdulkarim, M., Gumbleton, M., Quincoces, G., Peñuelas, I., Martín‐Arbella, N., & Irache, J. M. (2019) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2019.100006 · Cited by 25
Ramirez, L. M. F., Gobin, E., Aid, R., Journé, C., Moraes, F. C., Picton, L., Cerf, D. L., Letourneur, D., Chauvierre, C., & Chaubet, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116457 · Cited by 25
Caldeira, T. G., Ruiz-Picazo, A., Lozoya-Agulló, I., Saúde-Guimarães, D. A., González‐Álvarez, M., de Souza, J., González‐Álvarez, I., & Bermejo, M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.022 · Cited by 24
Analysis of aqueous humour proteins in patients with retinoblastoma
Hadjistilianou, T., Giglioni, S., Micheli, L., Vannoni, D., Brogi, E., Cevenini, G., Cortelazzo, A., Francesco, S. D., Menicacci, F., & Leoncini, R. (2011) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02711.x · Cited by 20
Wohlleben, W., Coleman, V. A., & Gilliland, D. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814182-3.00015-8 · Cited by 8
Cited by
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
Nanotechnology–General Aspects: A Chemical Reduction Approach to the Synthesis of Nanoparticles
Szczyglewska, P., Feliczak-Guzik, A., & Nowak, I. (2023) · Molecules · doi:10.3390/molecules28134932 · Cited by 377
Wang, K., Yang, R., Li, J., Wang, H., Wan, L., & He, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591438 · Cited by 27
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Mashweu, A. R., & Azov, V. A. (2024) · doi:10.20944/preprints202410.2092.v1 · Cited by 10
Metadata
- Authors
- Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2022-04-18
- Volume
- 14
- Issue
- 4
- Pages
- 883
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4224214472
- Cited by
- 531
- References
- 175
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.